Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.
A 49-year-old woman with severe demyelinating syndrome systemic lupus erythematosus (DS-SLE), where lupus affects the white matter in the brain, was successfully treated with Genentech‘s Rituxan (rituximab), along with other ... Read more
Genes found in African-Americans with systemic lupus erythematosus (SLE) may explain why they have a higher risk of atherosclerosis, a heart disease in which fatty deposits can clog arteries. The ... Read more
The U.S. Food and Drug Administration (FDA) has granted orphan drug status to the investigative therapy blisibimod for the treatment of immunoglobulin A nephropathy (IgAN), according to Anthera Pharmaceuticals, the ... Read more
Researchers at Denver’s National Jewish Health have prevented autoimmune disease in mice prone to a lupus-like illness by eliminating a protein called T-bet. This protein, which helps transform a type of white ... Read more
Galapagos will collaborate with Gilead on a Phase 2 trial evaluating the effectiveness and safety of filgotinib as a treatment for the skin disease cutaneous lupus erythematosus (CLE). Lupus is an ... Read more
Mycophenolate mofetil (MMF) was tested in laboratory mice with a systemic lupus erythematosus (SLE)-like disease, and was found to lower the animals’ blood pressure, levels of autoantibodies, and the ... Read more